PREMIER partners will present at SETAC Europe 33rd annual meeting in Dublin: don´t miss out!

This year SETAC Europe conference brings an exciting scientific programme addressing the overarching theme of “Data-driven environmental decision-making” for the protection and restoration of the environment.  A variety of PREMIER partners from both public and private partners and Scientific Advisory Members will attend.  

We will present our work in poster sessions, asking for input of SETAC participants. Besides this, some consortium members will chair sessions on Pharmaceuticals in the environment, Environmental policy, or assessing sustainability of chemicals and products. 

Don´t miss out the PREMIER posters and presentations!  

Including criteria for GREENER active pharmaceutical ingredients in the R&D process: opportunities and need for tools and assaysMoermond et al.Monday 1 May, session 7.02 – poster 406
Comparative Study on the Intrinsic Clearances of Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss) Subcellular S9 Fractions and 3D Primary Hepatocyte CulturesPihlaja et al.Tuesday, 2 May 2023, session 1.01.P – poster 011
Establishment of a novel public database and digital assessment system (DAS) on pharmaceuticals in the environment (PIE) in the EUWölz et al.Wednesday 3 May, session 3.13.P – poster 159
Prioritization, learnings, and strategies to close data gaps of the active pharmaceutical ingredient disulfiramWölz et al. Wednesday 3 May, session 3.13.P – poster 121
Prioritisation of Pharmaceuticals for Assessment of Exposure and Risks to Terrestrial EcosystemsAshfield et al.Wednesday 3 May, Session 3.13.P – Poster 119
Criteria to Assess the Relevance and Reliability of Environmental Threshold Concentrations (ETCs) for PharmaceuticalsMoermond et al.Thursday 4 May, session 6.04 – poster 398

Platform presentations:

Jiaqi Wang, Jan A.J. Hendriks and Ad M. J. Ragas (RU) – Session: 4.08 Exposure and Effect Assessment of Ionic and Ionizable Organic Chemicals, Title: A Food Web Bioaccumulation Model for Pharmaceuticals in Aquatic Ecosystems

Monday, 1 May 2023

The present study aimed to develop a food web bioaccumulation model for pharmaceuticals in aquatic ecosystems and evaluate its performance.

Cannata et al. – Session: 3.13.A Data-gap driven prioritization of active pharmaceuticals ingredients based on predicted environmental risk

Wednesday, 3 May 2023

The different approaches that can be adopted to prioritize APIs include the exposure-based approach, the hazard-based approach, and the risk-based approach. In this work, we followed a risk-based prioritization approach, combining the environmental exposure concentration (measured or predicted environmental concentration; MEC or PEC, respectively) with the Predicted No Effect Concentration (PNEC).

Take a look below for more information on the sessions chaired: 

Stewart Owen (AZ) and others – Session 3.04. Application of Biomonitoring Approaches to Support Surveillance of Chemical Exposure in the Environment 

Monday 1 May, 8:45 and 10:45, Wicklow Hall 1 

The aim of this session will be to demonstrate the application of biomonitoring in the field to identify opportunities and challenges in the use of this approach and provide a forum for discussion to increase its adoption. 


John Wilkinson, Todd Davidson, Ad M. J. Ragas (RU) and others – Session 3.134Human and Veterinary Pharmaceuticals in the Environment – Risk, Prioritisation & New Insights 

Wednesday 3 May, 8:45, 10:45 and 13:35, Liffey A 

The purpose of this session is to highlight advances in the prioritisation, ERA and monitoring of human and veterinary APIs in all environmental compartments. Also welcome are advances in fields such as API transport, fate, exposure (monitoring and modelling), effects, impact analysis, regulatory tools, guideline development and risk mitigation approaches.  


Caroline Moermond (RIVM) Irene Bramke (AZ) and others–  – Session 7.02. Better Safe than Sorry: Safe, Sustainable and Circular Chemicals, Materials and Products along their Lifecycle 

Monday 1 May, 8:45, Wicklow Hall 2A 

An important challenge lies in the assessment of safety (for humans as well as the environment) and sustainability of substances and products, where some trade-offs may exit. We will examine to what extent human and ecological hazard and risk assessment data may be integrated into an assessment framework with Life Cycle Analysis (LCA) criteria (e.g., carbon footprint, water use, land use, raw material use intensity, resource depletion and re-use) or wider sustainability aspects (economic, social).